Sharon L Bober1,2, E Fine3, C J Recklitis3,4. 1. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Sharon_bober@dfci.harvard.edu. 2. Harvard Medical School, Boston, MA, USA. Sharon_bober@dfci.harvard.edu. 3. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. 4. Harvard Medical School, Boston, MA, USA.
Abstract
PURPOSE: Each year, thousands of young breast cancer (BC) patients confront the difficult decision to medically suppress ovarian function and undergo abrupt, premature menopause to reduce risk of cancer recurrence. Unlike natural menopause, young women undergoing ovarian suppression (OS) face severe and disruptive side effects. Profound sexual dysfunction is one of the most prevalent, distressing side effects of OS treatment. Unmanaged sexual dysfunction is also a primary predictor of non-adherence to this potentially life-saving treatment. We developed and tested a brief, psychosexual intervention targeted to manage sexual dysfunction and psychological distress after OS in young BC survivors. METHODS:Twenty young BC survivors with sexual dysfunction received a single 4-h group intervention that included sexual health rehabilitation, body awareness exercises, and mindfulness-based cognitive therapy (MBCT) skills followed by a single tailored booster telephone call 1-month later. Assessment of female sexual function and psychological distress was completed at baseline and 2 months post-intervention. RESULTS: Analyses examined changes pre- to post-intervention. Female sexual health improved significantly from baseline to follow-up (n = 19, p < 0.02). Anxiety was also significantly improved at the 2-month (p < 0.000) timepoint, compared with baseline 1. Moderate-to-large effect sizes were observed regarding changes in sexual function and psychological distress. CONCLUSIONS: Significant improvements in sexual functioning and psychological distress were observed 2 months post-intervention. IMPLICATIONS FOR CANCER SURVIVORS: These results demonstrate that delivery of a targeted intervention in brief, low-intensity group setting is a promising model for reducing distressing sexual dysfunction in young BC survivors on OS treatment.
RCT Entities:
PURPOSE: Each year, thousands of young breast cancer (BC) patients confront the difficult decision to medically suppress ovarian function and undergo abrupt, premature menopause to reduce risk of cancer recurrence. Unlike natural menopause, young women undergoing ovarian suppression (OS) face severe and disruptive side effects. Profound sexual dysfunction is one of the most prevalent, distressing side effects of OS treatment. Unmanaged sexual dysfunction is also a primary predictor of non-adherence to this potentially life-saving treatment. We developed and tested a brief, psychosexual intervention targeted to manage sexual dysfunction and psychological distress after OS in young BC survivors. METHODS: Twenty young BC survivors with sexual dysfunction received a single 4-h group intervention that included sexual health rehabilitation, body awareness exercises, and mindfulness-based cognitive therapy (MBCT) skills followed by a single tailored booster telephone call 1-month later. Assessment of female sexual function and psychological distress was completed at baseline and 2 months post-intervention. RESULTS: Analyses examined changes pre- to post-intervention. Female sexual health improved significantly from baseline to follow-up (n = 19, p < 0.02). Anxiety was also significantly improved at the 2-month (p < 0.000) timepoint, compared with baseline 1. Moderate-to-large effect sizes were observed regarding changes in sexual function and psychological distress. CONCLUSIONS: Significant improvements in sexual functioning and psychological distress were observed 2 months post-intervention. IMPLICATIONS FOR CANCER SURVIVORS: These results demonstrate that delivery of a targeted intervention in brief, low-intensity group setting is a promising model for reducing distressing sexual dysfunction in young BC survivors on OS treatment.
Entities:
Keywords:
Breast cancer; Sexual health; Sexual rehabilitation
Authors: Sharon L Bober; Christopher J Recklitis; Jennifer Bakan; Judy E Garber; Andrea F Patenaude Journal: J Sex Med Date: 2014-10-14 Impact factor: 3.802
Authors: Karin Ribi; Weixiu Luo; Jürg Bernhard; Prudence A Francis; Harold J Burstein; Eva Ciruelos; Meritxell Bellet; Lorenzo Pavesi; Ana Lluch; Marilena Visini; Vani Parmar; Carlo Tondini; Pierre Kerbrat; Antonia Perelló; Patrick Neven; Roberto Torres; Davide Lombardi; Fabio Puglisi; Per Karlsson; Thomas Ruhstaller; Marco Colleoni; Alan S Coates; Aron Goldhirsch; Karen N Price; Richard D Gelber; Meredith M Regan; Gini F Fleming Journal: J Clin Oncol Date: 2016-03-28 Impact factor: 44.544
Authors: Dominique Frechette; Lise Paquet; Shailendra Verma; Mark Clemons; Paul Wheatley-Price; Stan Z Gertler; Xinni Song; Nadine Graham; Susan Dent Journal: Breast Cancer Res Treat Date: 2013-08-14 Impact factor: 4.872
Authors: Christopher J Recklitis; Susan K Parsons; Mei-Chiung Shih; Ann Mertens; Leslie L Robison; Lonnie Zeltzer Journal: Psychol Assess Date: 2006-03
Authors: Jasmine S Sukumar; Dionisia Quiroga; Mahmoud Kassem; Michael Grimm; Namrata Vilas Shinde; Leslie Appiah; Marilly Palettas; Julie Stephens; Margaret E Gatti-Mays; Ashley Pariser; Mathew Cherian; Daniel G Stover; Nicole Williams; Jeffrey Van Deusen; Robert Wesolowski; Maryam Lustberg; Bhuvaneswari Ramaswamy; Sagar Sardesai Journal: Breast Cancer Res Treat Date: 2021-09-08 Impact factor: 4.872
Authors: Jennifer Barsky Reese; Areej El-Jawahri; Kristen Sorice; Christina Cruz; Sharon L Bober; Mary B Daly; Lauren A Zimmaro; Mary Catherine Beach; Elaine Wittenberg; Antonio C Wolff; Elizabeth Handorf; Stephen J Lepore Journal: Support Care Cancer Date: 2022-03-29 Impact factor: 3.359